Lung ultrasound and short-term prognosis in heart failure patients

Cogliati, Chiara; Casazza, Giovanni; Ceriani, Elisa; Torzillo, Daniela; Furlotti, Stefano; Bossi, Ilaria; Vago, Tarcisio; Costantino, Giorgio; Montano, Nicola

doi:10.1016/j.ijcard.2016.05.010

Cited by 79 publications

(66 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Several papers demonstrated the additive diagnostic power of LUS in the early diagnosis of HF and its application has been inserted in the guidelines recommendation. [20][21][22][23][24][25] Current findings has been reported by Gargani et al and recently confirmed by Coiro in 60 patients during shorter follow up period. [20,21] Anyway no data are currently reported about the building of specific score counting clinical signs, echo and BNP data together with LUS measurement in either HFrEF and HFpEF [Table 4]…”

Section: Discussionsupporting

confidence: 61%

Combined use of lung ultrasound, B-type natriuretic peptide, and echocardiography for outcome prediction in patients with acute HFrEF and HFpEF

et al. 2018

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 61%

Combined use of lung ultrasound, B-type natriuretic peptide, and echocardiography for outcome prediction in patients with acute HFrEF and HFpEF

et al. 2018

View full text Add to dashboard Cite

show abstract

“…All-cause mortality rates in recent AHF trials including both patients with HFrEF and those with HFpEF range from 12% for 90 days to 11-21% for 180 days of follow-up. 11 All-cause mortality rates were lower (4.0% and 7.4%) in two of the AHF trials 25,30 we reviewed despite follow-up periods and age ranges similar to those in recent AHF trials. However, these AHF trials enrolled patients with lower mean ejection fraction than the trials included in our review, which may explain the associated higher mortality rates in these trials.…”

Section: Does Lung Ultrasound Provide Prognostic Information In Heartmentioning

confidence: 90%

“…All acute dyspnoea and AHF studies reported the performance of concomitant echocardiography and two also reported assessment of pleural effusions. 25,30 Neither of the studies in chronic HF reported concomitant assessment of echocardiography, but one included pleural effusions. 14…”

Section: Ultrasound Equipment Imaging Protocols and Analysismentioning

confidence: 99%

Dynamic changes and prognostic value of pulmonary congestion by lung ultrasound in acute and chronic heart failure: a systematic review

Platz

Merz

Jhund

et al. 2017

European J of Heart Fail

206

175

View full text Add to dashboard Cite

Aims Pulmonary congestion is an important finding in patients with heart failure (HF) that can be quantified by lung ultrasound (LUS). We conducted a systematic review to describe dynamic changes in LUS findings of pulmonary congestion (B-lines) in HF and to examine the prognostic utility of B-lines in HF. Methods and results We searched online databases for studies conducted in patients with chronic or acute HF that used LUS to assess dynamic changes or the prognostic value of pulmonary congestion. We included studies in adult populations, published in English, and conducted in ≥25 patients. Of 1327 identified studies, 13 (25–290 patients) met the inclusion criteria: six reported on dynamic changes in LUS findings (438 patients) and seven on the prognostic value of B-lines in HF (953 patients). In acute HF, B-line number changed within as few as 3 h of HF treatment. In acute HF, ≥15 B-lines on 28-zone LUS at discharge identified patients at a more than five-fold risk for HF readmission or death. Similarly, in ambulatory patients with chronic HF, ≥3 B-lines on five- or eight-zone LUS marked those at a nearly four-fold risk for 6-month HF hospitalization or death. Conclusions Lung ultrasound findings change rapidly in response to HF therapy. This technique may represent a useful and non-invasive method to track dynamic changes in pulmonary congestion. Furthermore, residual congestion at the time of discharge in acute HF or in ambulatory patients with chronic HF may identify those at high risk for adverse events.

show abstract

“…Pulmonary congestion is one of the most important findings in heart failure (HF), yet traditional methods, such as clinical examination and chest X‐ray, are relatively insensitive for its detection . Recently, there has been tremendous growth in the use of lung ultrasound (LUS) for the detection of pulmonary congestion in HF both in research and, more recently, in clinical practice . LUS has been proposed as a useful tool in the assessment of patients with both acute and chronic HF .…”

Section: Introductionmentioning

confidence: 99%

Expert consensus document: Reporting checklist for quantification of pulmonary congestion by lung ultrasound in heart failure

Platz

Jhund

Girerd

et al. 2019

European J of Heart Fail

108

View full text Add to dashboard Cite

Lung ultrasound is a useful tool for the assessment of patients with both acute and chronic heart failure, but the use of different image acquisition methods, inconsistent reporting of the technique employed and variable quantification of 'B-lines,' have all made it difficult to compare published reports. We therefore need to ensure that future studies utilizing lung ultrasound in the assessment of heart failure adopt a standardized approach to reporting the quantification of pulmonary congestion. Strategies to improve patient care by use of lung ultrasound in the assessment of heart failure have been difficult to develop. In the present document, key aspects of standardization are discussed, including equipment used, number of chest zones assessed, the method of quantifying B-lines, the presence and timing of additional investigations (e.g. natriuretic peptides and echocardiography) and the impact of therapy. This consensus report includes a checklist to provide standardization in the preparation, review and analysis of manuscripts. This will serve as a guide for investigators and clinicians and enhance the quality and transparency of lung ultrasound research.

show abstract

Lung ultrasound and short-term prognosis in heart failure patients

Cited by 79 publications

References 28 publications

Combined use of lung ultrasound, B-type natriuretic peptide, and echocardiography for outcome prediction in patients with acute HFrEF and HFpEF

Combined use of lung ultrasound, B-type natriuretic peptide, and echocardiography for outcome prediction in patients with acute HFrEF and HFpEF

Dynamic changes and prognostic value of pulmonary congestion by lung ultrasound in acute and chronic heart failure: a systematic review

Expert consensus document: Reporting checklist for quantification of pulmonary congestion by lung ultrasound in heart failure

Contact Info

Product

Resources

About